Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension

It is widely accepted that impaired bioavailability of endothelial nitric oxide (NO) plays a critical role in the pathophysiology of pulmonary arterial hypertension (PAH). However, there are published data that show that relatively many PAH patients respond favorably to acetylcholine‐induced pulmona...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Physiol Rep
Autores principales: Tanaka, Mariko, Abe, Kohtaro, Oka, Masahiko, Saku, Keita, Yoshida, Keimei, Ishikawa, Tomohito, McMurtry, Ivan F., Sunagawa, Kenji, Hoka, Sumio, Tsutsui, Hiroyuki
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727286/
https://ncbi.nlm.nih.gov/pubmed/29208691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13537
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares